Depression Clinical Trial
— BridgeOfficial title:
A Randomized Controlled Trial of "The Bridge", a Peer Health Navigation Intervention
NCT number | NCT02022462 |
Other study ID # | Bridge2014 |
Secondary ID | PCORI |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 2014 |
Est. completion date | March 2020 |
Verified date | May 2023 |
Source | University of Southern California |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The mortality rate among people with Serious Mental Illness (SMI) is 2 to 3 times that of the general population, meaning that those with a serious mental illness die, on average, 25 years earlier than those without an SMI. These deaths are largely attributed to preventable medical conditions, many of which are more common in the SMI population. The "Bridge" intervention is a peer navigator model that was developed to target factors that negatively impact healthcare access, utilization, and outcomes among individuals with serious mental illness (e.g., severe mood disorders and psychotic disorders). This intervention targets male and female, adult consumers across races/ethnicities and has been utilized by Pacific Clinics (Southern California's largest behavioral healthcare agency) and the Department of Mental Health of Los Angeles County to improve the health and quality of life for their consumers. Investigators will test the comparative effectiveness of a peer navigator intervention (the Bridge) to treatment as usual. The Bridge navigator intervention is designed to teach SMI consumers the skills to engage health care providers and to overcome motivational deficits in order to improve their health and healthcare use. The specific aims of this application are: 1. To use randomized methods to examine the effectiveness of the Bridge intervention on the health care utilization, satisfaction with care, health status, and health care self-management for a sample of individuals with severe mental illness receiving public mental health services in the community; 2. To use randomized methods to examine the effectiveness of the Bridge intervention on psychological and social well-being for a sample of individuals with severe mental illness receiving public mental health services in the community. 151 participants in an Full Service Partnership (FSP) clinic operated by Pacific Clinics were recruited to participate in an approximately 24-month long study of Bridge navigation. Participants will be randomly assigned to either treatment as usual (waitlist) or immediate intervention with the Bridge. Participants in both groups will complete three assessments (baseline, 6 months, 12 months) and statistically compared over time. Staff stakeholders (n = 20) will also be interviewed at baseline and every three months of the study in order to ensure that the intervention is being implemented appropriately.
Status | Completed |
Enrollment | 151 |
Est. completion date | March 2020 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Client participants will have diagnoses of serious mental illness and be between the ages of 18-65. All participants must be able to complete assessments in English. - Staff participants will be between the ages of 18-65 and must be currently employed at Pacific Clinics. All participants must be able to complete assessments in English. - Medical providers who serve clients of Pacific Clinics will also be interviewed as stakeholders. They will be between the ages of 18-65 and must be employees of a medical provider serving Pacific Clinics' clients. Exclusion Criteria: - Clients who are under the age of 18, over the age of 65, who are under conservatorship, cannot give informed consent themselves, or are not receiving mental health services through Pacific Clinics will not be eligible for participation. - Staff participants must be currently employed at Pacific Clinics and have the capacity to give informed consent themselves. - Medical providers must be serving Pacific Clinics' clients and have the capacity to give informed consent themselves. |
Country | Name | City | State |
---|---|---|---|
United States | Pacific Clinics El Camino | Santa Fe Springs | California |
Lead Sponsor | Collaborator |
---|---|
University of Southern California | University of California, Los Angeles |
United States,
Bazelon Center for Mental Health Law. Get it together. How to integrate physical and mental health care for people with serious mental disorders. Washington DC 2004.
DE Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Moller HJ, Ndetei DM, Newcomer JW, Uwakwe R, Leucht S. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011 Feb;10(1):52-77. doi: 10.1002/j.2051-5545.2011.tb00014.x. — View Citation
Gelberg L, Andersen RM, Leake BD. The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000 Feb;34(6):1273-302. — View Citation
Parks J, Svendsen D, Singer P, Foti ME. Morbidity and mortality in people with serious mental illness. Report from the National Association of State Mental Health Program Directors. 2006.
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changed Score on SF-12 Pain Items From Baseline to 6 Months and 12 Months | Changed score on SF-12 pain items from baseline to 6 months and 12 months in active intervention group and changed score from 6 months to 12 months in the waitlist control group. A z-score of 0 is equal to the mean and is considered normal. Lower numbers indicate values lower than the mean and higher numbers indicate values higher than the mean. Higher values are indicative of more pain. A negative change score indicates less pain. The SF-12 is a widely used preference-based utility measure of health derived from the SF-36. | baseline, 6 months, 12 months | |
Primary | Changed Health Screenings From Baseline to 6 Months and 12 Months | Changed health screenings (e.g., pap smear, diabetes screening, blood pressure) from baseline to 6 months and 12 months for active intervention group and from 6 months to 12 months for waitlist control group. Clients select from a list of 8 possible routine screenings for ones they have completed in the last 6 months or since their last assessment. A higher change score indicates an increased rate of health screenings (which could reflect better care) and a lower score indicates fewer health screenings. Scores ranged from -6 to 7. | baseline, 6 months, 12 months | |
Primary | Changed Number of Health Complaints From Baseline to 6 and 12 Months | Changed number of Health Complaints from baseline to 6 and 12 months for the active intervention group and from 6 to 12 months by the waitlist control group. Participants will select yes/no whether they currently are experiencing any of 24 common health symptoms in the last 6 months. A count of the number of health complaints will be used in analyses. A negative change score would indicate a reduction in symptoms, which would indicate better health. Change scores ranged from -21 to 7. | baseline, 6 months, 12 months | |
Primary | Changed Scores on Health Care Efficacy Scale From Baseline to 6 Months and 12 Months | Changed scores on The Health Care Efficacy Scale from baseline to 6 months and 12 months for the active intervention group and for the waitlist control group from 6 months to 12 months. This scale has been adapted from the Mental Health Confidence Scale, which was developed to measure the self-efficacy in individuals with a mental illness. This 14-item scale includes items on skills such as appointment making, pharmacy visits, establishing a medical home, and feeling that healthcare needs were heard and addressed. Participants will estimate the frequency of these experiences on a 3 point scale (1 = 'never' to 3 = '3 or more times'). A positive change score indicates improved health care self-efficacy. | baseline, 6 months, 12 months | |
Primary | Changed Score on Primary Care Provider Relationship From Baseline to 6 and 12 Months | Changed ratings of a high-quality relationship with primary care providers from baseline to 6 and 12 months for active intervention group and from 6 months compared to 12 months for waitlist intervention group. Participants will be asked if they have a primary care provider (yes/no). Patients with a routine primary care provider will complete the Engagement with the Healthcare Provider Scale (as done with their navigator) regarding their relationship with their primary care provider. Mean scores range from 1 to 5 and the reported scores reflect the change in those scores from baseline to 6 months and 6 months to 12 months. A negative score indicates fewer issues with their healthcare provider over time in terms of units on a scale. | baseline, 6 months, 12 months | |
Secondary | Changed Scores on Provider Level Stigma From Baseline in Comparison to 6 and 12 Months | Changed ratings of provider stigma from baseline to 6 and 12 months for the immediate treatment group and from 6 months to 12 months for the waitlist control group. Provider-level stigma will be measured with a scale adapted from a provider level stigma scale in individuals with HIV/AIDS. This 7-item scale measures the degree to which clients experience stigma when they interact with health care providers, with items adapted to reflect SMI rather than HIV/AIDS. Participants rate their stigmatizing experiences with their provider on a 5-point scale (1= 'strongly disagree' to 5 = 'strongly agree'). Mean scores range from 1 to 5 with higher scores indicating agreement with experiences of stigma. | baseline, 6 months, 12 months | |
Secondary | Changed Scores of General Life Satisfaction From Baseline to 6 and 12 Months | Changed scores of life satisfaction by the immediate treatment group from baseline to 6 and 12 months and from 6 months to 12 months for the waitlist control group. The Satisfaction with Life scale (SWL) is an 18-item Likert scale which measures participants' satisfaction with life in four domains: living situation, social relationship, work, and self and present life. It has shown good inter-item reliability (alpha = .88) and factorial validity in studies of the SMI. Mean scores range from 1 to 5, with higher scores indicating greater satisfaction with life. Change scores ranged from -1.42 to 1.59 with higher scores indicating an improvement over time in life satisfaction. | baseline, 6 months, 12 months | |
Secondary | Changed Scores on BASIS-24 From Baseline in Comparison to 6 and 12 Months | Changed ratings of issues from baseline in comparison to 6 and 12 months assessments for immediate intervention group and from 6 months to 12 months for waitlist control group. The functional outcomes of the clients will be measured with the BASIS-24 (Behavior and Symptom Identification Scale). The 24 items of the BASIS-32 have been designed to assess a client's perception of difficulty due to psychiatric symptoms and problems in functional areas (daily living skills, work, and social) over the past week. Higher scores indicate greater difficulty. Scores range from 0 to 4. Change scores range from -2.18 to 1.58 with a positive score indicating an increase in difficulties. | baseline, 6 months, 12 months | |
Secondary | Changed Unhealthy Habits From Baseline to 6 and 12 Months | Using 1 item adapted from the National Leisure Time Survey, participants rated on a 7 point scale (0 = 'never' to 7 = 'daily') the frequency that participants exercise and scores were converted into z scores. A z-score of 0 is equal to the mean and is considered normal. Lower numbers indicate values lower than the mean and higher numbers indicate values higher than the mean. Higher values are indicative of more exercise. A negative change score indicates less exercise | baseline, 6 months, 12 months | |
Secondary | Changed Scores of Internalized Stigma From Baseline to 6 and 12 Months | Lower ratings of internalized stigma from baseline to 6 and 12 months for immediate intervention group and from 6 to 12 months for the waitlist control group. The 'Internalized Stigma of Mental Illness' scale (ISMI) will measure the internalized stigma of the clients along 5 dimensions of internalized stigma-alienation, stereotype endorsement, discrimination experience, social withdrawal and stigma resistance. Mean scores ranged from 1 to 4 with higher scores indicating a higher level of self-stigma. Change scores ranged from -.88 to 1.13, with negative change scores indicating a decrease in internalized stigma and a positive score indicating an increase in internalized stigma. | baseline, 6 months, 12 months | |
Secondary | ChangedPrescribed Medications From Baseline to 6 and 12 Months | A decrease in medications is expected from baseline to 6 and 12 months for immediate treatment group and for the waitlist control group from 6 months to 12 months. Current medications are recorded for their name, dosage, frequency, timing, dates started, side effects noted, and reasons prescribed. A positive score indicates an increase in medications and a negative change score indicates a reduction in medications. | baseline, 6 months, 12 months | |
Secondary | Changed Number of Health Diagnoses From Baseline to 6 and 12 Months | Changed rates of identification of previously undetected chronic health conditions, decreased number of other disorders from baseline to 6 and 12 months in active intervention group and from 6 to 12 months in the waitlist control group. Changes in the number of diagnoses ranged from -3 to 5. Positive changes indicate an increased in diagnosed conditions and negative scores indicate a reduction in diagnoses. | baseline, 6 months, 12 months | |
Secondary | Changed Euroqual Health Score From Baseline to 6 and 12 Months | Changed rating of Euroqual health score from baseline to 6 and 12 months by active intervention group and from 6 months to 12 months for the waitlist control group. Participants rate their health from highest possible to worst possible from 100 to 0. Change scores ranged from -90 to 100. Positive scores indicate better health and negative scores indicate worsening health. | baseline, 6 months, and 12 months | |
Secondary | Changed Euroqual Satisfaction With Provider Score From Baseline to 6 and 12 Months | Changed rating of Euroqual satisfaction with provider score from baseline to 6 and 12 months by active intervention group and from 6 months to 12 months for the waitlist control group. Participants rate their satisfaction from highest possible to worst possible from 100 to 0. Change scores ranged from -90 to 79. Positive scores indicate improved satisfaction and negative scores indicate declines in satisfaction. | baseline, 6 months, and 12 months | |
Secondary | Changed Substance Use From Baseline to 6 and 12 Months | Changed substance use from baseline to 6 and 12 months for the immediate treatment group and for the waitlist control group from 6 months to 12 months (e.g., alcohol, nicotine, cocaine, marijuana, prescription drugs). Scores ranged from 0 to 9, with a higher number indicating a greater variety of substances used. A negative score indicates a reduced variety of substances used and a positive score indicates an increase in the variety of substances used (range from -2 to 2 for change scores). | baseline, 6 months, 12 month | |
Secondary | Changed Score on Self Management Motivation | Changed score on Self Management Motivation scale from baseline to 6 months and 12 months in active intervention group and changed score from 6 months to 12 months in the waitlist control group. 9 item measure written for this study. Participants rate how important and how confident they are about managing their health (1 = not at all confident to 10 = very confident). Changes in confidence ranged from -4.44 to 4.00. Positive scores indicate an increased confidence and negative scores indicate a decrease in confidence. | baseline, month 6, month 12 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |